PACB
Pacific Biosciences Of California, Inc.Company with tickers: PACB
CIK
1299130
CUSIP
69404D108
Shares Outstanding
310,601,688
Website
https://www.pacb.com
13F Activity (30d)
11 filings
2 filers
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| John F. Milligan, Ph.D. | Class III Director | Appointed | 2026-06-04 |
| Christian O. Henry | Class III Director | Appointed | 2026-06-04 |
| Chris Gibson, Ph.D. | Class III Director | Appointed | 2026-06-04 |
| Christopher M. Smith | Class III Director | Appointed | 2026-06-04 |
| Kathy Ordoñez | Class III Director | Appointed | 2026-06-04 |
| William Ericson | Class III Director | Appointed | 2026-06-04 |